Alkem Laboratories completes acquisition of 51-55% stake in Occlutech Holding AG

Alkem Laboratories, through its wholly owned subsidiary Alkem Medtech Private Limited, has completed the acquisition of a 51-55% stake in Swiss medical device manufacturer Occlutech Holding AG. The transaction was funded by a ₹1,100 crore capital infusion into Alkem Medtech.

“Alkem Laboratories announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has completed the acquisition of at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG.”scanx.trade

• 1 source
• scanx.tradeAlkem Laboratories completes acquisition of 51-55% stake in Occlutech Holding AGDhanJul 17, 2026

Summarized from public sources; check the original articles before acting on it.